Pregnant women's choices for preventing respiratory syncytial virus (RSV)

被引:0
|
作者
Wang, Bing [1 ,2 ,3 ]
Lassi, Zohra [4 ,5 ]
Andraweera, Prabha [1 ,2 ,3 ]
Chen, Gang [6 ]
Ong, Jason J. [7 ,8 ]
Mcmillian, Mark [1 ,2 ,3 ]
Marshall, Helen [1 ,2 ,3 ]
机构
[1] Womens & Childrens Hlth Network, Vaccinol & Immunol Res Trials Unit, 72 King William Rd, Adelaide, SA 5006, Australia
[2] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Adelaide, Robinson Res Inst, Adelaide, Australia
[5] Univ Adelaide, Fac Hlth & Med Sci, Sch Publ Hlth, Adelaide, Australia
[6] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia
[7] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[8] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England
关键词
RSV; Maternal vaccine; Vaccine attitudes; Qualitative; Vaccine promotion; VACCINATION; CHALLENGES; CHILDREN;
D O I
10.1016/j.vaccine.2025.126790
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in infants and can lead to severe respiratory distress, especially in very young infants. No specific treatments exist for RSV. However, new preventative strategies have become available including RSV vaccine for pregnant women and monoclonal antibody for infants. This study aimed to identify and understand barriers and facilitators to the uptake of a new RSV vaccine in pregnant women and determine their underlying choices for a maternal RSV immunisation program. Additionally, the study investigated choice for maternal vaccination or administration of a long-lasting monoclonal antibody to infants. Methods: Eligible participants were pregnant women residing in Australia and aged 18 years or older. Focus group discussions and individual online interviews were conducted and data were analysed using a thematic analysis approach. Results: A total of 34 pregnant women participated in online focus group discussions or interviews, with an average age of 34 years. The identified themes were categorised into four overarching domains: 1) motivators for vaccinating during pregnancy to safeguard their babies and prevent severe diseases, 2) barriers to vaccination including vaccine safety concerns, uncertainties regarding vaccine effectiveness, and vaccine hesitancy arising from COVID-19 vaccination experiences, 3) preferred vaccination promotion strategies, including constant reminders/prompts, personalised messages, campaign focusing on serious outcomes and using diverse/lay languages, recommendations from local obstetricians and health authorities, 4) clear vaccine recommendation policies and a preference for maternal immunisation over infant immunisation. Conclusions: The maternal RSV vaccination was generally welcomed and preferred by pregnant women in our study comparing to other strategies. Preferences for RSV program promotion included diversity in languages, "nudge" reminders, and recommendations from healthcare providers.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] PROGRESS IN THE SURVEILLANCE OF RESPIRATORY SYNCYTIAL VIRUS (RSV) IN EUROPE: 2001-2008
    Meerhoff, T. J.
    Mosnier, A.
    Schellevis, F.
    Paget, W. J.
    EUROSURVEILLANCE, 2009, 14 (40): : 14 - 18
  • [42] COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
    Gastaldi, Andrea
    Dona, Daniele
    Barbieri, Elisa
    Giaquinto, Carlo
    Bont, Louis J.
    Baraldi, Eugenio
    CHILDREN-BASEL, 2021, 8 (12):
  • [43] Interpreting Respiratory Syncytial Virus (RSV) Nucleoprotein Mutations: A Structural and Functional Perspective
    Hassan, Mubashir
    Shahzadi, Saba
    Yasir, Muhammad
    Kloczkowski, Andrzej
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 356 - 365
  • [44] The Efficiency of p27 Cleavage during In Vitro Respiratory Syncytial Virus (RSV) Infection Is Cell Line and RSV Subtype Dependent
    Rezende, Wanderson
    Ye, Xunyan
    Angelo, Laura S.
    Carisey, Alexandre F.
    Avadhanula, Vasanthi
    Piedra, Pedro A.
    JOURNAL OF VIROLOGY, 2023, 97 (05)
  • [45] Respiratory Syncytial Virus (RSV) Burden in Infants in the Kingdom of Saudi Arabia and the Impact of All-Infant RSV Protection: A Modeling Study
    Alharbi, Adel
    Yousef, Abdullah
    Zubani, Amal
    Alzahrani, Mohammad
    Al-Hindi, Mohammad
    Alharbi, Saleh
    Alahmadi, Turki
    Alabdulkarim, Hana
    Kazmierska, Paulina
    Beuvelet, Matthieu
    ADVANCES IN THERAPY, 2024, 41 (04) : 1419 - 1435
  • [46] Respiratory syncytial virus infections
    Wetzke, M.
    Schwerk, N.
    PNEUMOLOGE, 2019, 16 (04): : 232 - 241
  • [47] Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood
    Lu, Susan
    Hartert, Tina V.
    Everard, Mark L.
    Giezek, Hilde
    Nelsen, Linda
    Mehta, Anish
    Patel, Hima
    Knorr, Barbara
    Reiss, Theodore F.
    PEDIATRIC PULMONOLOGY, 2016, 51 (12) : 1382 - 1392
  • [48] Subtractive Immunization as a Method to Develop Respiratory Syncytial Virus (RSV)-Specific Monoclonal Antibodies
    Jacobs, Lotte
    Stobbelaar, Kim
    Heykers, Annick
    Cos, Paul
    Delputte, Peter
    ANTIBODIES, 2023, 12 (04)
  • [49] Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022
    Munkstrup, Charlotte
    Lomholt, Frederikke Kristensen
    Emborg, Hanne-Dorthe
    Moller, Karina Lauenborg
    Krog, Jesper Schak
    Trebbien, Ramona
    Vestergaard, Lasse S.
    EUROSURVEILLANCE, 2023, 28 (01) : 2 - 7
  • [50] A Classification Study of Respiratory Syncytial Virus (RSV) Inhibitors by Variable Selection with Random Forest
    Hao, Ming
    Li, Yan
    Wang, Yonghua
    Zhang, Shuwei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2011, 12 (02) : 1259 - 1280